title: A case of ecthyma during therapy with an epidermal growth factor receptor inhibitor.
authors.affiliation: Department of Dermatology.
authors.forename: Takashi
authors.initials: T
authors.lastname: Mizuno
authors.affiliation: Department of Dermatology.
authors.forename: Tomohiko
authors.initials: T
authors.lastname: Tanegashima
authors.affiliation: Department of Dermatology.
authors.forename: Aki
authors.initials: A
authors.lastname: Suzuki
authors.affiliation: Department of Dermatology.
authors.forename: Sayaka
authors.initials: S
authors.lastname: Kuze
authors.affiliation: Department of Surgery, Odawara Municipal Hospital, Kuno 46, Odawara-shi, Kanagawa-ken, Japan.
authors.forename: Takashi
authors.initials: T
authors.lastname: Koyama
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002081:Buttocks / Q000473:pathology; D002166:Camptothecin / Q000031:analogs & derivatives / Q000627:therapeutic use; D000068818:Cetuximab; D003110:Colonic Neoplasms / Q000188:drug therapy*; D004473:Ecthyma / Q000139:chemically induced* / Q000473:pathology; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D000077544:Panitumumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000077544:Panitumumab; D066246:ErbB Receptors; D000068818:Cetuximab; D002955:Leucovorin; D005472:Fluorouracil; D002166:Camptothecin